Gainers
-
CAS Medical Systems Inc (NASDAQ: CASM)
shares surged 53.8 percent to $2.41 after Edwards Lifesciences Corp (NYSE: EW) agreed to acquire the company for $2.45 per share in cash.
-
Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 40.5 percent to $0.6183 after the company signed a term sheet
with TheraCann International for an exclusive license of CertainT platform for legal cannabis and Hemp.
-
Ellie Mae Inc (NYSE: ELLI) climbed 21.3
percent to $99.35 after the company announced it will be acquired by private equity firm Thoma Bravo for $99 per share.
-
AGM Group Holdings Inc. (NASDAQ: AGMH)
rose 19.3 percent to $34.00.
-
Mimecast Limited (NASDAQ: MIME) shares
jumped 17.9 percent to $50.48 after reporting upbeat Q3 results. The company also issued Q4 sales guidance above analyst
estimates.
-
SCWorx Corp. (NASDAQ: WORX) shares
surged 17.3 percent to $6.92 after the company reported a three-year, $785 thousand new customer service contract.
-
Pyxus International, Inc. (NYSE: PYX)
jumped 16.8 percent to $20.27 after reporting Q3 results.
-
ADMA Biologics, Inc. (NASDAQ: ADMA)
rose 15.4 percent to $3.3225 after the company disclosed that it has entered into a $72.5 million loan facility with Perceptive
Advisors.
-
Tronox Limited (NYSE: TROX) gained 14.7
percent to $10.23 after the FTC staff filed a joint motion requesting a delay of remaining appeals deadline to resolve
competitive concerns over Tronox's pending acquisition of The National Titanium Dioxide Company Limited.
-
Coty Inc. (NYSE: COTY) shares climbed
13.7 percent to $10.98 after JAB proposed a partial tender offer to acquire additional shares at $11.65 per share in cash.
-
Brighthouse Financial, Inc. (NASDAQ: BHF) gained 12.5 percent to $40.17 following Q4 results.
-
OneMain Holdings, Inc. (NYSE: OMF) shares
rose 11.9 percent to $33.48 after reporting upbeat Q4 results.
-
Jones Lang LaSalle Incorporated (NYSE: JLL) climbed 11.1 percent to $162.56 following strong Q4 results.
-
SAExploration Holdings, Inc. (NASDAQ: SAEX) gained 10.6 percent to $3.96.
-
Dermira, Inc. (NASDAQ: DERM) gained
9.9 percent to $7.66. Almirall and Dermira entered into option and license agreement for European rights to Lebrikizumab.
-
Aviat Networks, Inc. (NASDAQ: AVNW)
jumped 9.9 percent to $16.02 after reporting Q2 results.
-
Frontline Ltd. (NYSE: FRO) shares climbed
9.2 percent to $5.49 after gaining 2.65 percent on Monday.
-
Chegg, Inc. (NYSE: CHGG) rose 9.1
percent to $37.96 after the company reported better-than-expected fourth-quarter results and issued strong first-quarter and
FY2019 sales guidance.
-
IPG Photonics Corporation (NASDAQ: IPGP) gained 9.1 percent to $149.71 after the company reported Q4 results. The
company said it expects Q1 EPS of $1.00 to $1.20 versus the $1.43 analyst estimate on weaker than expected sales.
-
BEST Inc. (NYSE: BSTI) shares surged 9
percent to $5.53.
-
LiveRamp Holdings, Inc. (NASDAQ: RAMP)
shares rose 8.7 percent to $47.92 following Q3 earnings.
-
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) surged 7.7 percent to $47.80.
-
Viking Therapeutics, Inc. (NASDAQ: VKTX) gained 7 percent to $8.67.
-
STMicroelectronics N.V. (NYSE: STM) rose
5.6 percent to $16.59 after the company unveiled its HVLED001B LED lighting controller.
Check out these big penny stock gainers and
losers
Losers
-
Bristow Group Inc (NYSE: BRS) shares
tumbled 32.4 percent to $2.07 after the company terminated its planned acquisition of Columbia Helicopters and reported soft Q3
results. Bristow will pay a $20 million fee as a result of the merger termination.
-
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) dipped 17.2 percent to $4.35 after reporting 1.86 million share common
stock and 1.39 million in warrants offering.
-
Xeris Pharmaceuticals, Inc. (NASDAQ: XERS) dropped 16.7 percent to $12.25 after reporting a 5 million share common
stock offering.
-
Varonis Systems, Inc. (NASDAQ: VRNS)
shares declined 16.3 percent to $53.52 after the company issued weak guidance.
-
Multi-Color Corporation (NASDAQ: LABL)
dropped 14 percent to $43.85 after the company reported downbeat Q3 results. The company also issued FY19 EPS guidance below
analyst estimates.
-
MoneyGram International, Inc. (NASDAQ: MGI) dipped 11.9 percent to $2.2650 following downbeat Q4 results. The company
also sees FY19 sales to decline 2 percent to 4 percent.
-
NETGEAR, Inc. (NASDAQ: NTGR) shares
fell 11.8 percent to $34.74.
-
Livent Corporation (NYSE: LTHM) fell
10.9 percent to $11.69 after the company reported downbeat Q4 results and issued weak Q1 forecast.
-
Nektar Therapeutics (NASDAQ: NKTR)
dropped 10.3 percent to $41.58 after the company announced a 48 percent response rate for its urothelial cancer treatment
versus 60 percent previously.
-
PHI, Inc. (NASDAQ: PHII) tumbled 10.1
percent to $4.63.
-
Gilat Satellite Networks Ltd. (NASDAQ: GILT) dropped 9.9 percent to $8.55 following Q4 results.
-
DiaMedica Therapeutics Inc. (NASDAQ: DMAC) dipped 9.9 percent to $3.10.
-
Molson Coors Brewing Company (NYSE: TAP)
fell 9.3 percent to $59.30 following weak Q4 sales. The company also announced plans to restate its 2016 and 2017 financial
statements.
-
ToughBuilt Industries, Inc. (NASDAQ: TBLT) fell 8.5 percent to $2.25. ToughBuilt reported a partnership with
WingPoint Group to help launch and manage company's Amazon online store front and overall online presence.
-
Farmer Bros. Co. (NASDAQ: FARM) dipped
7.6 percent to $23.78 after reporting Q2 results.
-
Molina Healthcare, Inc. (NYSE: MOH)
tumbled 7.6 percent to $126.69 following Q4 results.
-
Enochian Biosciences Inc. (NASDAQ: ENOB) dipped 7.5 percent to $7.86.
-
Misonix, Inc. (NASDAQ: MSON) shares
declined 7.3 percent to $17.58.
-
China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) shares fell 7 percent to $2.15.
-
Gilead Sciences, Inc. (NASDAQ: GILD)
fell 5.2 percent to $64.11 after reporting that topline data from phase 3 STELLAR-4 study of Selonsertib in compensated
Cirrhosis due to NASH did not meet its primary endpoint.
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.